Once again the FDA has updated the label on the drug Tysabri. Tysabri, manufactured by Biogen Idec, Inc. and Elan Corp. Plc., is used by pateints with multiple sclerosis. Signs of liver damage occurred in some patients taking the drug. Liver problems may lead to death or the need for a transplant.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.